Morphine - Ethypharm

Drug Profile

Morphine - Ethypharm

Alternative Names: Morphine - Xanodyne; Morphine sulfate SR Multicaps®; Morphine sulfate sustained-release Multicaps®; Morphine sulphate SR Multicaps®; Morphine sulphate sustained-release Multicaps®; Oramorph

Latest Information Update: 13 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ethypharm
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 11 Sep 2013 Biomarkers information updated
  • 30 May 2002 Launched for Pain in Canada (PO)
  • 30 May 2002 Launched for Pain in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top